{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:28:22Z","timestamp":1786447702718,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LTGY24H160036"],"award-info":[{"award-number":["LTGY24H160036"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guizhou Provincial Basic Research Program","award":["QKHJC- ZD (2025) 021"],"award-info":[{"award-number":["QKHJC- ZD (2025) 021"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273287"],"award-info":[{"award-number":["82273287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2025C02067"],"award-info":[{"award-number":["2025C02067"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anaplastic thyroid carcinoma (ATC) exhibits extreme malignancy with a median survival of less than 6\u00a0months. Traditional therapeutic approaches yield limited efficacy, necessitating the urgent identification of novel treatment strategies. The tumor hypoxic microenvironment serves as a key driver of ATC progression and drug resistance, in which the transcription factor hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) orchestrates key processes in regulating tumor metabolism, immune evasion, and resistance to cell death. Ferroptosis is a novel iron-dependent form of programmed death, defined by excessive peroxidation of polyunsaturated fatty acid phospholipids (PUFA-PL) within cellular membranes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this study, cellular and xenograft models were employed to demonstrate that hypoxia confers ferroptosis resistance to ATC cells. Lipid metabolomics analysis revealed HIF-1\u03b1 regulates lipid metabolism, and acyl-CoA synthase 4 (ACSL4) was identified as key lipid metabolism-related candidate. Chromatin immunoprecipitation (ChIP) and dual-luciferase reporter assays were used to assess the binding of HIF-1\u03b1 to the hypoxia-response element (HRE) within the ACSL4 promoter region. Flow cytometric analysis was performed to investigate how HIF-1\u03b1 inhibition augments the antitumor immunogenicity of PD-1 blockade, as evidenced by enhanced intratumoral CD8\n                      <jats:sup>+<\/jats:sup>\n                      T-cell infiltration and cytokine secretion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This study identifies a key mechanism by which HIF-1\u03b1 provides ferroptosis resistance in ATC under the intrinsically hypoxic tumor microenvironment. HIF-1\u03b1 directly binds the HRE within the ACSL4 promoter, transcriptionally repressing ACSL4 and consequently curtailing PUFA-PL biosynthesis, thereby conferring ferroptosis resistance on ATC cells. In addition, combined treatment with HIF-1\u03b1 inhibitor and PD-1 blockade effectively suppresses tumor progression and enhances intratumoral CD8\n                      <jats:sup>+<\/jats:sup>\n                      T-cell infiltration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study elucidates the molecular mechanism by which HIF-1\u03b1 mediates anti-ferroptosis in ATC through regulating lipid metabolism and proposes a promising therapeutic strategy in which HIF-1\u03b1 inhibition acts synergistically with PD-1 blockade for the treatment of ATC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s11658-026-00973-1","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:15:44Z","timestamp":1782540944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HIF-1\u03b1 enhances ferroptosis resistance in anaplastic thyroid carcinoma by suppressing ACSL4-mediated lipid metabolic homeostasis"],"prefix":"10.1186","volume":"31","author":[{"given":"Renjie","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyue","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juyong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"3","key":"973_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/thy.2020.0944","volume":"31","author":"KC Bible","year":"2021","unstructured":"Bible KC, Kebebew E, Brierley J, Brito JP, Cabanillas ME, Clark TJ Jr, et\u00a0al. 2021 American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer: American Thyroid Association anaplastic thyroid cancer guidelines task force. Thyroid. 2021;31(3):337\u201386. https:\/\/doi.org\/10.1089\/thy.2020.0944.","journal-title":"Thyroid"},{"issue":"2","key":"973_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ecl.2021.11.020","volume":"51","author":"A Maniakas","year":"2022","unstructured":"Maniakas A, Zafereo M, Cabanillas ME. Anaplastic thyroid cancer: new horizons and challenges. Endocrinol Metab Clin North Am. 2022;51(2):391\u2013401. https:\/\/doi.org\/10.1016\/j.ecl.2021.11.020.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"973_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101678","volume":"37","author":"SN Rao","year":"2023","unstructured":"Rao SN, Smallridge RC. Anaplastic thyroid cancer: an update. Best Pract Res Clin Endocrinol Metab. 2023;37(1):101678. https:\/\/doi.org\/10.1016\/j.beem.2022.101678.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"9","key":"973_CR4","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1001\/jamaoncol.2020.3362","volume":"6","author":"A Maniakas","year":"2020","unstructured":"Maniakas A, Dadu R, Busaidy NL, Wang JR, Ferrarotto R, Lu C, et\u00a0al. Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000\u20132019. JAMA Oncol. 2020;6(9):1397\u2013404. https:\/\/doi.org\/10.1001\/jamaoncol.2020.3362.","journal-title":"JAMA Oncol"},{"issue":"8067","key":"973_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-025-08974-4","volume":"642","author":"T Ca\u00f1eque","year":"2025","unstructured":"Ca\u00f1eque T, Baron L, M\u00fcller S, Carmona A, Colombeau L, Versini A, et\u00a0al. Activation of lysosomal iron triggers ferroptosis in cancer. Nature. 2025;642(8067):492\u2013500. https:\/\/doi.org\/10.1038\/s41586-025-08974-4.","journal-title":"Nature"},{"issue":"5","key":"973_CR6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et\u00a0al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"issue":"4","key":"973_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"XJ Jiang","year":"2021","unstructured":"Jiang XJ, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382. https:\/\/doi.org\/10.1038\/s41580-020-00324-8.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"973_CR8","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li JB, Kang R, Klionsky DJ, Tang DL. Ferroptosis: machinery and regulation. Autophagy. 2021;17(9):2054\u201381. https:\/\/doi.org\/10.1080\/15548627.2020.1810918.","journal-title":"Autophagy"},{"issue":"2","key":"973_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2020.11.024","volume":"81","author":"B Yan","year":"2021","unstructured":"Yan B, Ai YW, Sun Q, Ma Y, Cao Y, Wang JW, et\u00a0al. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol Cell. 2021;81(2):355-369.e10. https:\/\/doi.org\/10.1016\/j.molcel.2020.11.024.","journal-title":"Mol Cell"},{"issue":"3","key":"973_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","volume":"8","author":"A Seiler","year":"2008","unstructured":"Seiler A, Schneider M, F\u00f6rster H, Roth S, Wirth EK, Culmsee C, et\u00a0al. Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 2008;8(3):237\u201348. https:\/\/doi.org\/10.1016\/j.cmet.2008.07.005.","journal-title":"Cell Metab"},{"issue":"6","key":"973_CR11","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","volume":"30","author":"BR Stockwell","year":"2020","unstructured":"Stockwell BR, Jiang XJ, Gu W. Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol. 2020;30(6):478\u201390. https:\/\/doi.org\/10.1016\/j.tcb.2020.02.009.","journal-title":"Trends Cell Biol"},{"issue":"5","key":"973_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s43018-025-00937-y","volume":"6","author":"L Zhou","year":"2025","unstructured":"Zhou L, Lian GY, Zhou T, Cai Z, Yang S, Li WN, et\u00a0al. Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity. Nat Cancer. 2025;6(5):768\u201385. https:\/\/doi.org\/10.1038\/s43018-025-00937-y.","journal-title":"Nat Cancer"},{"issue":"1","key":"973_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41419-025-07710-0","volume":"16","author":"X Zhang","year":"2025","unstructured":"Zhang X, Fang Y, Rong D, et\u00a0al. A novel taxane SB-T-101141 triggers a noncanonical ferroptosis to overcome paclitaxel resistance of breast cancer via iron homeostasis-related KHSRP. Cell Death Dis. 2025;16(1):403. https:\/\/doi.org\/10.1038\/s41419-025-07710-0.","journal-title":"Cell Death Dis"},{"issue":"6","key":"973_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101281","volume":"11","author":"R Ren","year":"2024","unstructured":"Ren R, Chen Y, Zhou Y, et\u00a0al. STIM1 promotes acquired resistance to sorafenib by attenuating ferroptosis in hepatocellular carcinoma. Genes Dis. 2024;11(6):101281. https:\/\/doi.org\/10.1016\/j.gendis.2024.101281.","journal-title":"Genes Dis"},{"issue":"1","key":"973_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02577-2","volume":"24","author":"X Zhu","year":"2025","unstructured":"Zhu X, Lin S, Ruan L, et\u00a0al. HNRNPC reprograms cancer metabolism to drive acquired chemoresistance in colorectal cancer by repressing of Nrf2\/SLC7A11-dependent ferroptosis. Cell Commun Signal. 2025;24(1):26. https:\/\/doi.org\/10.1186\/s12964-025-02577-2.","journal-title":"Cell Commun Signal"},{"key":"973_CR16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.freeradbiomed.2025.07.013","volume":"238","author":"X Wang","year":"2025","unstructured":"Wang X, Liu T, Fei Y, et\u00a0al. RTA-408 overcomes cisplatin-resistant lung cancer by inhibiting WWP1-mediated NCOA4 ubiquitination to induce ferritinophagy and ferroptosis. Free Radic Biol Med. 2025;238:595\u2013610. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.07.013.","journal-title":"Free Radic Biol Med"},{"issue":"34","key":"973_CR17","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A. 2016;113(34):E4966\u201375. https:\/\/doi.org\/10.1073\/pnas.1603244113.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"973_CR18","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","volume":"10","author":"SJ Dixon","year":"2015","unstructured":"Dixon SJ, Winter GE, Musavi LS, Lee ED, Snijder B, Rebsamen M, et\u00a0al. Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem Biol. 2015;10(7):1604\u20139. https:\/\/doi.org\/10.1021\/acschembio.5b00245.","journal-title":"ACS Chem Biol"},{"issue":"3","key":"973_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.freeradbiomed.2005.08.044","volume":"40","author":"RM Adibhatla","year":"2006","unstructured":"Adibhatla RM, Hatcher JF. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med. 2006;40(3):376\u201387. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2005.08.044.","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"973_CR20","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3109\/10715762.2010.498478","volume":"44","author":"A Negre-Salvayre","year":"2010","unstructured":"Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, et\u00a0al. Pathological aspects of lipid peroxidation. Free Radic Res. 2010;44(10):1125\u201371. https:\/\/doi.org\/10.3109\/10715762.2010.498478.","journal-title":"Free Radic Res"},{"issue":"5","key":"973_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.freeradbiomed.2009.05.032","volume":"47","author":"E Niki","year":"2009","unstructured":"Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med. 2009;47(5):469\u201384. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.05.032.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"973_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41556-021-00818-3","volume":"24","author":"HL Zhang","year":"2022","unstructured":"Zhang HL, Hu BX, Li ZL, Du T, Shan JL, Ye ZP, et\u00a0al. PKC\u03b2II phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis. Nat Cell Biol. 2022;24(1):88\u201398. https:\/\/doi.org\/10.1038\/s41556-021-00818-3.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"973_CR23","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.26599\/fshw.2022.9250204","volume":"5","author":"H Chen","year":"2024","unstructured":"Chen H, Chen LL, Wang WJ. Mechanisms and active substances of targeting lipid peroxidation in ferroptosis regulation. Food Sci Hum Wellness. 2024;5(5):2502\u201318. https:\/\/doi.org\/10.26599\/fshw.2022.9250204.","journal-title":"Food Sci Hum Wellness"},{"issue":"6","key":"973_CR24","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41556-025-01668-z","volume":"27","author":"ML Sassano","year":"2025","unstructured":"Sassano ML, Tyurina YY, Diokmetzidou A, Vervoort E, Tyurin VA, More S, et\u00a0al. Endoplasmic reticulum\u2013mitochondria contacts are prime hotspots of phospholipid peroxidation driving ferroptosis. Nat Cell Biol. 2025;27(6):902\u201317. https:\/\/doi.org\/10.1038\/s41556-025-01668-z.","journal-title":"Nat Cell Biol"},{"issue":"17","key":"973_CR25","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1016\/j.molcel.2025.08.006","volume":"85","author":"XS Liu","year":"2025","unstructured":"Liu XS, Zhao ZC, Bian ZX, Benthani FA, Hu YY, Liang DG, et\u00a0al. Endocytosis is essential for cysteine-deprivation-induced ferroptosis. Mol Cell. 2025;85(17):3333-3342.e4. https:\/\/doi.org\/10.1016\/j.molcel.2025.08.006.","journal-title":"Mol Cell"},{"issue":"2","key":"973_CR26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41588-018-0318-2","volume":"51","author":"V Bhandari","year":"2019","unstructured":"Bhandari V, Hoey C, Liu LY, Lalonde E, Ray J, Livingstone J, et\u00a0al. Molecular landmarks of tumor hypoxia across cancer types. Nat Genet. 2019;51(2):308\u201318. https:\/\/doi.org\/10.1038\/s41588-018-0318-2.","journal-title":"Nat Genet"},{"key":"973_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.semcancer.2022.12.011","volume":"88","author":"CH Liao","year":"2023","unstructured":"Liao CH, Liu XJ, Zhang C, Zhang Q. Tumor hypoxia: from basic knowledge to therapeutic implications. Semin Cancer Biol. 2023;88:172\u201386. https:\/\/doi.org\/10.1016\/j.semcancer.2022.12.011.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"973_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19213-4","volume":"8","author":"M Sato","year":"2018","unstructured":"Sato M, Kusumi R, Hamashima S, Kobayashi S, Sasaki S, Komiyama Y, et\u00a0al. The ferroptosis inducer erastin irreversibly inhibits system xc\u2212 and synergizes with cisplatin to increase cisplatin\u2019s cytotoxicity in cancer cells. Sci Rep. 2018;8(1):968. https:\/\/doi.org\/10.1038\/s41598-018-19213-4.","journal-title":"Sci Rep"},{"issue":"13","key":"973_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cells13131074","volume":"13","author":"MM Zaruba","year":"2024","unstructured":"Zaruba MM, Staggl S, Ghadge SK, Maurer T, Gavranovic-Novakovic J, Jeyakumar V, et\u00a0al. Roxadustat attenuates adverse remodeling following myocardial infarction in mice. Cells. 2024;13(13):1074. https:\/\/doi.org\/10.3390\/cells13131074.","journal-title":"Cells"},{"issue":"9","key":"973_CR30","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s00125-024-06185-6","volume":"67","author":"S M\u00e4kinen","year":"2024","unstructured":"M\u00e4kinen S, Sree S, Ala-Nisula T, Kultalahti H, Koivunen P, Koistinen HA. Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men. Diabetologia. 2024;67(9):1943\u201354. https:\/\/doi.org\/10.1007\/s00125-024-06185-6.","journal-title":"Diabetologia"},{"issue":"4","key":"973_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115487","volume":"44","author":"WJ Li","year":"2025","unstructured":"Li WJ, Chen YC, Lin YA, Zou YQ, Hu GS, Yang JJ, et\u00a0al. Hypoxia-induced PRMT1 methylates HIF2\u03b2 to promote breast tumorigenesis via enhancing glycolytic gene transcription. Cell Rep. 2025;44(4):115487. https:\/\/doi.org\/10.1016\/j.celrep.2025.115487.","journal-title":"Cell Rep"},{"issue":"1","key":"973_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51882-w","volume":"15","author":"R Chen","year":"2024","unstructured":"Chen R, Lin ZY, Shen SQ, Zhu CX, Yan K, Suo CX, et\u00a0al. Citrullination modulation stabilizes HIF-1\u03b1 to promote tumour progression. Nat Commun. 2024;15(1):7654. https:\/\/doi.org\/10.1038\/s41467-024-51882-w.","journal-title":"Nat Commun"},{"issue":"4","key":"973_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/s0891-5849(02)00848-1","volume":"33","author":"GPC Drummen","year":"2002","unstructured":"Drummen GPC, van Liebergen LCM, Op den Kamp JAF, Post JA. C11-BODIPY(581\/591), an oxidation-sensitive fluorescent lipid peroxidation probe: (micro)spectroscopic characterization and validation of methodology. Free Radic Biol Med. 2002;33(4):473\u201390. https:\/\/doi.org\/10.1016\/s0891-5849(02)00848-1.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"973_CR34","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/s0014-5793(99)00696-1","volume":"453","author":"EH Pap","year":"1999","unstructured":"Pap EH, Drummen GP, Winter VJ, Kooij TW, Rijken P, Wirtz KW, et\u00a0al. Ratio-fluorescence microscopy of lipid oxidation in living cells using C11-BODIPY(581\/591). FEBS Lett. 1999;453(3):278\u201382. https:\/\/doi.org\/10.1016\/s0014-5793(99)00696-1.","journal-title":"FEBS Lett"},{"issue":"9","key":"973_CR35","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.theriogenology.2011.01.002","volume":"75","author":"A Partyka","year":"2011","unstructured":"Partyka A, Baumber DA, Maples KR, et\u00a0al. Detection of lipid peroxidation in frozen-thawed avian spermatozoa using C11-BODIPY 581\/591. Theriogenology. 2011;75(9):1623\u20139. https:\/\/doi.org\/10.1016\/j.theriogenology.2011.01.002.","journal-title":"Theriogenology"},{"issue":"24","key":"973_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413521","volume":"25","author":"TC Krapoth","year":"2024","unstructured":"Krapoth TC, Henle GS, Avdyli M, Bekti\u0107 B, Schwarzkopf KM, Be\u0161i\u0107 L, et\u00a0al. Wanted: dead or alive cells with propidium iodide staining in liver tissue. Int J Mol Sci. 2024;25(24):13521. https:\/\/doi.org\/10.3390\/ijms252413521.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"973_CR37","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cmet.2024.11.010","volume":"37","author":"X Wang","year":"2025","unstructured":"Wang X, Wu Q, Zhong MJ, Chen Y, Wang YD, Li X, et\u00a0al. Adipocyte-derived ferroptotic signaling mitigates obesity. Cell Metab. 2025;37(3):673-691.e7. https:\/\/doi.org\/10.1016\/j.cmet.2024.11.010.","journal-title":"Cell Metab"},{"issue":"11","key":"973_CR38","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1021\/acs.analchem.3c05430","volume":"96","author":"SY Wang","year":"2024","unstructured":"Wang SY, Qu YC, Shao N, Niu LY, Yang QZ. Reversible dual fluorescence-lifetime imaging of mitochondrial GSH and microviscosity: real-time evaluation of ferroptosis status. Anal Chem. 2024;96(11):4570\u20139. https:\/\/doi.org\/10.1021\/acs.analchem.3c05430.","journal-title":"Anal Chem"},{"issue":"1","key":"973_CR39","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41467-020-15109-y","volume":"11","author":"J Cao","year":"2020","unstructured":"Cao J, Chen XB, Jiang L, Lu B, Yuan M, Zhu DF, et\u00a0al. DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase. Nat Commun. 2020;11(1):1251. https:\/\/doi.org\/10.1038\/s41467-020-15109-y.","journal-title":"Nat Commun"},{"issue":"5","key":"973_CR40","first-page":"1198","volume":"7","author":"YM Zhu","year":"2017","unstructured":"Zhu YM, Zang YW, Zhao F, et\u00a0al. Inhibition of HIF-1\u03b1 by PX-478 suppresses tumor growth of esophageal squamous cell cancer in vitro and in vivo. Am J Cancer Res. 2017;7(5):1198\u2013212.","journal-title":"Am J Cancer Res"},{"issue":"3","key":"973_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1158\/1535-7163.233.3.3","volume":"3","author":"S Welsh","year":"2004","unstructured":"Welsh S, Williams R, Kirkpatrick L, et\u00a0al. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1\u03b1. Mol Cancer Ther. 2004;3(3):233\u201344.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"973_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/1535-7163.MCT-07-0463","volume":"7","author":"MY Koh","year":"2008","unstructured":"Koh MY, Spivak-Kroizman T, Venturini S, Welsh S, Williams RR, Kirkpatrick DL, et\u00a0al. Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1\u03b1. Mol Cancer Ther. 2008;7(1):90\u2013100. https:\/\/doi.org\/10.1158\/1535-7163.MCT-07-0463.","journal-title":"Mol Cancer Ther"},{"issue":"28","key":"973_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301852","volume":"10","author":"L Liu","year":"2023","unstructured":"Liu L, Pang JJ, Qin DD, Li RC, Zou D, Chi K, et\u00a0al. Deubiquitinase OTUD5 as a novel protector against 4-HNE-triggered ferroptosis in myocardial ischemia\/reperfusion injury. Adv Sci. 2023;10(28):e2301852. https:\/\/doi.org\/10.1002\/advs.202301852.","journal-title":"Adv Sci"},{"issue":"7\u20139","key":"973_CR44","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1089\/ars.2023.0237","volume":"39","author":"JT Cui","year":"2023","unstructured":"Cui JT, Wang YK, Tian XT, Miao YY, Ma LF, Zhang CC, et\u00a0al. LPCAT3 is transcriptionally regulated by YAP\/ZEB\/EP300 and collaborates with ACSL4 and YAP to determine ferroptosis sensitivity. Antioxid Redox Signal. 2023;39(7\u20139):491\u2013511. https:\/\/doi.org\/10.1089\/ars.2023.0237.","journal-title":"Antioxid Redox Signal"},{"key":"973_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2018.00192","volume":"5","author":"H Jiang","year":"2019","unstructured":"Jiang H, Li ZQ, Huan CM, Jiang XC. Macrophage lysophosphatidylcholine acyltransferase 3 deficiency-mediated inflammation is not sufficient to induce atherosclerosis in a mouse model. Front Cardiovasc Med. 2019;5:192. https:\/\/doi.org\/10.3389\/fcvm.2018.00192.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"973_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MOL.0000000000000820","volume":"33","author":"L Lagrost","year":"2022","unstructured":"Lagrost L, Masson D. The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid remodeling enzyme, in health and disease. Curr Opin Lipidol. 2022;33(3):193\u20138. https:\/\/doi.org\/10.1097\/MOL.0000000000000820.","journal-title":"Curr Opin Lipidol"},{"issue":"21","key":"973_CR47","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","volume":"136","author":"KY Ding","year":"2023","unstructured":"Ding KY, Liu CB, Li L, Yang M, Jiang N, Luo SL, et\u00a0al. Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism. Chin Med J. 2023;136(21):2521\u201337. https:\/\/doi.org\/10.1097\/CM9.0000000000002533.","journal-title":"Chin Med J"},{"issue":"8","key":"973_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112945","volume":"42","author":"Z Yang","year":"2023","unstructured":"Yang Z, Su W, Wei X, Qu S, Zhao D, Zhou J, et\u00a0al. HIF-1\u03b1 drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1. Cell Rep. 2023;42(8):112945. https:\/\/doi.org\/10.1016\/j.celrep.2023.112945.","journal-title":"Cell Rep"},{"key":"973_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00223-6","volume":"5","author":"B Zhao","year":"2020","unstructured":"Zhao B, Ke K, Wang Y, et\u00a0al. HIF-1\u03b1 and HDAC1 mediated regulation of FAM99A-miR92a signaling contributes to hypoxia induced HCC metastasis. Signal Transduct Target Ther. 2020;5:118. https:\/\/doi.org\/10.1038\/s41392-020-00223-6.","journal-title":"Signal Transduct Target Ther"},{"issue":"6702","key":"973_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf1329","volume":"384","author":"D Mathew","year":"2024","unstructured":"Mathew D, Marmarelis ME, Foley C, Bauml JM, Ye D, Ghinnagow R, et\u00a0al. Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients. Science. 2024;384(6702):eadf1329. https:\/\/doi.org\/10.1126\/science.adf1329.","journal-title":"Science"},{"issue":"3","key":"973_CR51","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/107327481402100308","volume":"21","author":"DE Dolan","year":"2014","unstructured":"Dolan DE, Gupta S. PD-1 pathway inhibitors: changing the landscape of cancer immunotherapy. Cancer Control. 2014;21(3):231\u20137. https:\/\/doi.org\/10.1177\/107327481402100308.","journal-title":"Cancer Control"},{"key":"973_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114610","volume":"155","author":"Q Ning","year":"2025","unstructured":"Ning Q, Liu J, Liu S, et\u00a0al. TRx0237 induces apoptosis and enhances anti-PD-1 immunotherapeutic efficacy in anaplastic thyroid cancer. Int Immunopharmacol. 2025;155:114610. https:\/\/doi.org\/10.1016\/j.intimp.2025.114610.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"973_CR53","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12022-024-09832-1","volume":"35","author":"M Boruah","year":"2024","unstructured":"Boruah M, Agarwal S, Mir RA, et\u00a0al. Unravelling the reasons behind limited response to anti-PD therapy in ATC: a comprehensive evaluation of tumor-infiltrating immune cells and checkpoints. Endocr Pathol. 2024;35(4):419\u201331. https:\/\/doi.org\/10.1007\/s12022-024-09832-1.","journal-title":"Endocr Pathol"},{"key":"973_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58910-3","volume":"16","author":"Z Pan","year":"2025","unstructured":"Pan Z, Tan Z, Xu N, et\u00a0al. Integrative proteogenomic characterization reveals therapeutic targets in poorly differentiated and anaplastic thyroid cancers. Nat Commun. 2025;16:3601. https:\/\/doi.org\/10.1038\/s41467-025-58910-3.","journal-title":"Nat Commun"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-026-00973-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00973-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00973-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:31:32Z","timestamp":1786444292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11658-026-00973-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["973"],"URL":"https:\/\/doi.org\/10.1186\/s11658-026-00973-1","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal protocol was reviewed and approved by the Animal Ethics Committees of the Clinical Research Center, Zhejiang Provincial People\u2019s Hospital, and Zhejiang University of Technology, and was conducted in strict accordance with the guidelines of the International Council for Laboratory Animal Science. The approval numbers are 20241213844110 and ZH20250806046. The approval dates are 18 December 2024 and 6 August 2025.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read the manuscript and provided their consent for the submission.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"132"}}